TIGO ENERGY, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TIGO ENERGY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.54M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $54.01M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $145.23M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $81.32M | Mar 21, 2024 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.54B | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $54.01B | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $145.23B | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $81.32B | Mar 21, 2024 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.35M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($4.16M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $51.31M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $24.77M | Mar 21, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.88M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($62.75M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($984.0K) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($7.04M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($402.5K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.0K) | Apr 7, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.50M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($52.00M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($8.28M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($896.0K) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($415.9K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($2.0K) | Apr 7, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.24M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $9.86M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $9.50M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.68M | Mar 21, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.30M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($12.35M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($37.22M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($16.47M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($464.0K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($1.7K) | Apr 7, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $642.0K | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.29M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.11M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.15M | Mar 21, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.04M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $72.91M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $127.78M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $88.08M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $117.83M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $23.3K | Apr 7, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.41M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $64.53M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $64.95M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $56.63M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $244.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.5K | Apr 7, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.62M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $8.39M | Mar 19, 2026 |
| FY2025 | Dec 31, 2023 | $62.82M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | ($55.69M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2021 | ($49.90M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2020 | $21.8K | Mar 31, 2023 |
| FY2021 | Dec 31, 2019 | $23.8K | Apr 7, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.21M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $12.21M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $12.21M | Mar 20, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($140.41M) | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | ($138.53M) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | ($75.78M) | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | ($62.22M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($405.7K) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($3.2K) | Apr 7, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.67M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | $11.75M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | $4.41M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | $36.19M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $802.6K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $22.8K | Apr 7, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $50.00M | Mar 20, 2025 |
| FY2023 | Dec 31, 2023 | $50.00M | Mar 21, 2024 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 21, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | (2) | Mar 21, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.42M | Mar 19, 2026 |
| FY2025 | Dec 31, 2024 | 60.80M | Mar 19, 2026 |
| FY2024 | Dec 31, 2023 | 58.75M | Mar 20, 2025 |
| FY2023 | Dec 31, 2022 | 5.47M | Mar 21, 2024 |
| FY2021 | Dec 31, 2021 | 3.34M | Apr 7, 2022 |
| FY2021 | Dec 31, 2020 | 2.88M | Apr 7, 2022 |